Join date: Jun 4, 2018
May 5, 2022 ∙ 2 min
Aravax appoints Dr Brett Haumann to Board of Directors
06 May 2022, Melbourne, AUSTRALIA: Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy...
Mar 3, 2022 ∙ 3 min
Aravax opens IND for PVX108 Phase 2 trials and strengthens SAB
Phase 2 study of PVX108 to commence in United States and Australia Dr Robert A. Wood, professor of pediatrics at the Johns Hopkins...